PCVX SEC Filings: 8-K, 10-Q, S-3 & 424B – Vaxcyte

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Oct 8, 2026

424B5

REGISTERED OFFERING

Oct 8, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Jefferies

Oct 5, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Jefferies

Oct 5, 2026

424B5

February 2026 ATM | Offering amount: $500,000,000 | Bank: Leerink Partners LLC

Feb 24, 2026

424B5

FIXED PRICE OFFERING - COMMON STOCK | Offering amount: $550,000,000 | Shares: 11,000,000 | Price: $50.000 | Bank: BofA Securities

Jan 30, 2026

Registrations

TYPE

HEADLINE

FILED AT

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Oct 7, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 24, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 25, 2025

S-3ASR

Up to $400,000,000 Common Stock PROSPECTUS Jefferies May 24, 2024

May 24, 2024

S-8

Registration

Feb 27, 2024

S-8

Registration

Feb 27, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 23, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 23, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 28, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 28, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 18, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 15, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

T. Rowe Price Investment Management, Inc. (Filed by)

Nov 6, 2026

SCHEDULE 13G/A

T. Rowe Price Investment Management, Inc. (Filed by)

Nov 6, 2026

Cowan Elvia (Reporting)

Nov 4, 2026

Wassil Jim (Reporting)

Nov 4, 2026

144

Form 144 - Report of proposed sale of securities

Nov 2, 2026

144

Form 144 - Report of proposed sale of securities

Nov 2, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

May 14, 2025

CORRESP

Form CORRESP - Correspondence

May 7, 2025

LETTER

Form UPLOAD - SEC-generated letter

Apr 10, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 12, 2020

CORRESP

Form CORRESP - Correspondence

Jun 9, 2020

CORRESP

Form CORRESP - Correspondence

Jun 9, 2020

Vaxcyte, Inc. PCVX · SEC Filings